Dr. Esther Leah Fine, MD

Dr. Fine practices at Sutter Valley Medical Foundation in Roseville, California.

Dr. Fine's NPI, 1679745996, was assigned on March 26, 2008. Dr. Fine graduated from University Of Washington School Of Medicine in 2004. Dr. Fine's California license number on file is A96924.

Dr. Fine's primary practice is Sutter Valley Medical Foundation, at 3 Medical Plz, Roseville, CA 95661 in Placer County. The practice phone is (800) 470-0071.

Dr. Fine's primary practice is Sutter Valley Medical Foundation in Roseville, California. Dr. Fine is also affiliated with Sutter Roseville Medical Center. The medical group on file is SGMF Radiology. Dmand AI also links Dr. Fine to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fine practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Fine's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Fine is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Fine has a license on file in California.

Dmand AI lists acute sinusitis, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Fine treats.

CMS data shows 1,096 Medicare services from Dr. Fine across 10 procedure codes in 2024, for 536 Medicare patients. Medicare paid $104,799 for them. Every service was in an office.

CMS counts 536 Medicare patients who saw Dr. Fine in 2024. The largest group is 65 to 74, with 214 patients. 72% of them have high cholesterol, and 69% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fine's median patient age at 60, with 54% women.

In 2024, Dr. Fine wrote 415 Medicare Part D claims for 191 patients. 98% of them were for generic drugs. CMS names the drug for 327 of them, across 15 drugs with 11 or more claims each, at $5,803 in total drug cost. In 2023, CMS named 376 claims across 17 drugs.

Dr. Fine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fine as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Fine. Dr. Fine's most frequent co-authors are Hamid Reza Djalilian, MD and Michael Andrew German, MD.

CMS Open Payments shows 14 general payments to Dr. Fine from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $240.

Dmand AI lists 1 award for Dr. Fine, most recently CMS Stage 1 2012 in 2011.

Dr. Fine graduated from University Of Washington School Of Medicine in 2004.

Dr. Fine is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.